Marquette Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Marquette Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$525	Buy	+216	New	+$528	﹤0.01%	814

Other funds holding ORGO

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Marquette Asset Management's ORGO Position: Q2 2026 in Review

Marquette Asset Management opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 216 shares worth $525. The stake represents ﹤0.01% of the portfolio and ranks #814 among its holdings.

10 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Marquette Asset Management held 216 shares of Organogenesis Holdings worth $525 as of Q2 2026.
Organogenesis Holdings was a new Marquette Asset Management position in Q2 2026.
Organogenesis Holdings made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #814 holding.
10 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.